|
1
|
O’Hara SP, Mott JL, Splinter PL, Gores GJ
and LaRusso NF: MicroRNAs: key modulators of post-transcriptional
gene expression. Gastroenterology. 136:17–25. 2009.
|
|
2
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du WW, Fang L, Li M, et al: MicroRNA
miR-24 enhances tumor invasion and metastasis by targeting PTPN9
and PTPRF to promote EGF signaling. J Cell Sci. 126:1440–1453.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mulrane L, Madden SF, Brennan DJ, et al:
miR-187 is an independent prognostic factor in breast cancer and
confers increased invasive potential in vitro. Clin Cancer
Res. 18:6702–6713. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haflidadottir BS, Larne O, Martin M,
Persson M, Edsjo A, Bjartell A and Ceder Y: Upregulation of miR-96
enhances cellular proliferation of prostate cancer cells through
FOXO1. PLoS One. 8:e724002013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu D, He X, Chang Y, Xu C, Jiang X, Sun S
and Lin J: Inhibition of miR-96 expression reduces cell
proliferation and clonogenicity of HepG2 hepatoma cells. Oncol Rep.
29:653–661. 2013.PubMed/NCBI
|
|
9
|
Zhu W, Liu X, He J, Chen D, Hunag Y and
Zhang YK: Overexpression of members of the microRNA-183 family is a
risk factor for lung cancer: a case control study. BMC Cancer.
11:3932011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bandres E, Cubedo E, Agirre X, et al:
Identification by real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Myatt SS, Wang J, Monteiro LJ, et al:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin H, Dai T, Xiong H, et al: Unregulated
miR-96 induces cell proliferation in human breast cancer by
downregulating transcriptional factor FOXO3a. PLoS One.
5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takahashi C, Sheng Z, Horan TP, et al:
Regulation of matrix metalloproteinase-9 and inhibition of tumor
invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad
Sci USA. 95:13221–13226. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oh J, Takahashi R, Kondo S, et al: The
membrane-anchored MMP inhibitor RECK is a key regulator of
extracellular matrix integrity and angiogenesis. Cell. 107:789–800.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Noda M and Takahashi C: Recklessness as a
hallmark of aggressive cancer. Cancer Sci. 98:1659–1665. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Cheng S, Zhang G, et al: Low
expression of RECK indicates a shorter survival for patients with
invasive breast cancer. Cancer Sci. 103:1084–1089. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin HY, Chiang CH and Hung WC: STAT3
upregulates miR-92a to inhibit RECK expression and to promote
invasiveness of lung cancer cells. Br J Cancer. 109:731–738. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiang CH, Hou MF and Hung WC:
Up-regulation of miR-182 by β-catenin in breast cancer increases
tumorigenicity and invasiveness by targeting the matrix
metalloproteinase inhibitor RECK. Biochim Biophys Acta.
1830:3067–3076. 2013.
|
|
19
|
Xin C, Buhe B, Hongting L, et al:
MicroRNA-15a promotes neuroblastoma migration by targeting
reversion-inducing cysteine-rich protein with Kazal motifs (RECK)
and regulating matrix metalloproteinase-9 expression. FEBS J.
280:855–866. 2013.PubMed/NCBI
|
|
20
|
Gabriely G, Wurdinger T, Kesari S, Esau
CC, Burchard J, Linsley PS and Krichevsky AM: MicroRNA 21 promotes
glioma invasion by targeting matrix metalloproteinase regulators.
Mol Cell Biol. 28:5369–5380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li N, Tang B, Zhu ED, et al: Increased
miR-222 in H. pylori-associated gastric cancer correlated
with tumor progression by promoting cancer cell proliferation and
targeting RECK. FEBS Lett. 586:722–728. 2012.PubMed/NCBI
|
|
22
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
24
|
Iorio MV, Casalini P, Tagliabue E, Menard
S and Croce CM: MicroRNA profiling as a tool to understand
prognosis, therapy response and resistance in breast cancer. Eur J
Cancer. 44:2753–2759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo Q, Li X, Li J, et al: MiR-15a is
underexpressed and inhibits the cell cycle by targeting CCNE1 in
breast cancer. Int J Oncol. 43:1212–1218. 2013.PubMed/NCBI
|
|
26
|
Li J, Kong X, Zhang J, Luo Q, Li X and
Fang L: MiRNA-26b inhibits proliferation by targeting PTGS2 in
breast cancer. Cancer Cell Int. 13:72013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu S, Lu Z, Liu C, et al: miRNA-96
suppresses KRAS and functions as a tumor suppressor gene in
pancreatic cancer. Cancer Res. 70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vishwamitra D, Li Y, Wilson D, et al:
MicroRNA 96 is a post-transcriptional suppressor of anaplastic
lymphoma kinase expression. Am J Pathol. 180:1772–1780. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen RX, Xia YH, Xue TC and Ye SL:
Suppression of microRNA-96 expression inhibits the invasion of
hepatocellular carcinoma cells. Mol Med Rep. 5:800–804.
2012.PubMed/NCBI
|
|
30
|
Calin GA, Liu CG, Sevignani C, et al:
MicroRNA profiling reveals distinct signatures in B cell chronic
lymphocytic leukemias. Proc Natl Acad Sci USA. 101:11755–11760.
2004. View Article : Google Scholar : PubMed/NCBI
|
